Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Interaction of Dapagliflozin and Telmisartan in Healthy Adults
NCT06063109Phase 1Completed
- Sponsor
- THPharm
- Start
- Oct 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dapagliflozin and telmisartan in type 2 diabetes mellitus (T2DM) and hypertension (HTN) (2 arms), sponsored by THPharm. Primary endpoints: Area Under the Curve at Steady State, Maximum Plasma Concentration at Steady State and 1 more. Started Oct 2023; status: completed.
02
Drugs
dapagliflozintelmisartan
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on NCT06063109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06063109.